This new immunotherapy is particularly effective in several types of solid tumors, but it will take time to confirm its ...

An emerging oncology tool known as broad genomic profiling or BGP is increasingly being used to help identify targeted ...

Doctors call for urgent action as digestive cancers surge among young adults, highlighting the need for better screening and ...

Study suggests that utilizing RiskScore drives breast cancer screening tailored to individual riskSALT LAKE CITY, May 07, ...

Ahmad Tarhini, MD, PhD, discusses inherited genetic variations and genetic ancestry, particularly for patients with high-risk melanoma.

Bio-Techne Corporation’s TECH share price has surged by 5.82%, which has investors questioning if this is right time to sell.

The global oncology blood testing market is on the brink of a major transformation, with projections indicating a significant rise from USD 3,851.7 million in 2022 to USD 18,278.2 million by 2032.

Following immunotherapy treatments in the last decade, new therapeutic strategies for cancer are beginning to emerge.

Few cancers are passed from parent to child, but genetic testing can help identify people at higher risk. In Sidney Raskind's ...

The "Oncology Liquid Biopsy Market - A Global and Regional Analysis: Focus on Offering, Indication, Clinical Application, End User and Country-Level Analysis - Analysis and Forecast, 2025-2035" report ...

The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...